Matthew M Lei

16PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 11, 2026
Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas.

Lea Mantz, P Connor Johnson, Matthew Lei

|Oct 31, 2025
A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

J Erika Haydu, Robert A Redd, Matthew M Lei

|Jun 05, 2025
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia.

Andrew R Branagan, Clifton Mo, Matthew Lei

|May 06, 2025
Artificial intelligence-based muscle analysis risk assessment of treatment-related toxicity in metastatic colorectal cancer.

Matthew Lei, Ryan D Nipp, Erica Tavares

|Mar 14, 2025
Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury.

E Bridget Kim, Jack E Malespini, Matthew Lei

|Jan 15, 2025
Addition of an NK1 receptor antagonist to standard antiemetic prophylaxis in patients with B-cell lymphoma receiving EPOCH.

Sloane English, Matthew Lei, Mark Sorial

Pageof 3

Frequent Collaborators

6 joint publications

Jeremy S Abramson

5 joint publications

Jacob D Soumerai

3 joint publications

Andrew R Branagan

3 joint publications

Andrew J Yee